Huizhuo Xu1, Xiaowei Dai1, Xiaoyu Cheng2,*
1The First People's Hospital of Mengcheng County, Bozhou 233500, Anhui, China.
2The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei 230031, Anhui, China.
*Corresponding author: Xiaoyu Cheng
Abstract
Objective: To investigate the efficacy of combined treatment with Compound Danshen Droplet Pills and conventional Western medicine in the treatment of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI). Methods: From January 2021 to December 2024, 45 patients with coronary heart disease who underwent PCI for AMI in the First People’s Hospital of Mengcheng County were divided into two groups using a randomized numerical table method, with 22 cases in the observation group and 23 cases in the control group. Conventional drug therapy was used for the control group, and on this basis, combined treatment with Compound Danshen Droplet Pills was added before and after PCI in the observation group. The patency of blood vessels, the frequency of angina pectoris attacks, the Seattle Angina Questionnaire (SAQ) score, clinical efficacy, and traditional Chinese medicine (TCM) syndrome scores of the two groups before and after treatment were observed. Results: After treatment, the patency of blood vessels, the frequency of angina pectoris attacks, the SAQ score, the clinical markedly effective rate, and the TCM syndrome scores of the two groups were improved compared with those before treatment, and the observation group was better than the control group, with a statistically significant difference (P < 0.05). Conclusion: Combined treatment with Compound Danshen Droplet Pills and conventional Western medicine has a good therapeutic effect on the patency of blood vessels and symptom improvement after PCI surgery for AMI, which can effectively improve endothelial function and improve the quality of life.
References
[1] Summary of the “Report on Cardiovascular Health and Diseases in China 2021”. Chin J Cardiovasc Dis Res. 2022;20(07):577-596.
[2] Zhong C, Shi Z, Dai Q, et al. Systematic Evaluation of the Effect of Compound Danshen Dropping Pills Combined with Conventional Western Medicine Treatment on Inflammatory Factors and Cardiac Function in Patients with Acute Myocardial Infarction after Surgery. Chin J Evid-based Med. 2021;21(06):662-668.
[3] Yan L, Chen T, Chen Z. The Effect of Compound Danshen Dropping Pills on Myocardial Blood Supply in Patients with Coronary Heart Disease Undergoing Elective Surgery. J New Chin Med. 2022;54(01):63-65.
[4] Wang Z, Fan J, Zhang C, et al. Based on Data Mining to Explore the Prescription and Usage Rules and Academic Experience of National Famous Traditional Chinese Medicine Doctor Wang Xingkuan in the Treatment of Chest Obstruction and Heartache. Chin J Exp Tradit Med Formulae. 2023;29(05):204-215.
[5] Ying S, Chen Q, Liu X, et al. The Preventive Effect and Mechanism of Compound Danshen Dropping Pills on Contrast-Induced Nephropathy in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention. J Pract Cardiopulm Med. 2022;30(08):96-101.
[6] Cardiovascular Disease Branch of Chinese Medical Association, Editorial Committee of Chinese Journal of Cardiovascular Diseases. Diagnosis and Treatment Guidelines for Acute Myocardial Infarction (2019). Chin J Cardiol. 2019;47(10):766-783.
[7] Interventional Cardiology Group of Cardiovascular Disease Branch of Chinese Medical Association, Thrombosis Prevention Professional Committee of Cardiovascular Internal Medicine Physicians Association of China, Editorial Committee of Chinese Journal of Cardiovascular Diseases. Chinese Guidelines for Percutaneous Coronary Intervention (2016). Chin J Cardiol. 2016;44(5):382-400.
[8] Zhang B. Internal Medicine of Traditional Chinese Medicine. Beijing: People's Medical Publishing House; 2019. p. 590-592.
[9] Dong C, Chen H, Li Y. Clinical Efficacy of Compound Danshen Dropping Pills Combined with Ticagrelor in the Treatment of Angina Pectoris after PCI Surgery for Coronary Heart Disease. Chin J Integr Med Cardio-Cerebrovasc Dis. 2022;20(02):292-294.
[10] Pertiwi KR, Hillman RM, Scott CA, Chilton EL. Ischemia Reperfusion Injury Produces, and Ischemic Preconditioning Prevents, Rat Cardiac Fibroblast Differentiation: Role of KATP Channels. J Cardiovasc Dev Dis. 2019;26(2):292-294.
[11] Ma X, Yang J, Ma G, et al. Modernization Research Progress of Traditional Chinese Medicine Salvia miltiorrhiza. Chin J Chin Mater Med. 2022;47(19):5131-5139.
[12] Huang Y, Cheng J, Shi Y, et al. Research Progress of Panax Notoginseng Chemical Components, Chromatographic Analysis, Panax Notoginseng Extract and Pharmacological Activity in Recent Five Years. Chin J Chin Mater Med. 2022;47(10):2584-2596.
[13] Wu Y, Zhu ZY, Chen J, et al. Research Progress of the Pharmacological Effects of Borneol and Borneol Acetate. Pharm Res. 2020;39(04):217-224.
[14] Chen K, Chen M, Wang Q, et al. Discussion on the Potential Molecular Mechanism of Compound Danshen Drops for the Treatment of Angina Pectoris Based on Network Pharmacology and Molecular Docking Technology. Drug Eval Res. 2022;45(07):1282-1293.
[15] Zhang Y, Chen X. Effect Analysis of Compound Danshen Drops Combined with Tirofiban to Improve Coronary Artery Slow Flow and Local Microcirculation Disorder of Myocardium in 62 Cases After Percutaneous Coronary Intervention. Anhui Med J. 2020;24(08):1639-1642.
[16] Gao D, Li T, Niu J, et al. Research Progress of Compound Danshen Drops in the Treatment and Safety of Cardiovascular Diseases. Guangming J Chin Med. 2021;36(17):2877-2880.
[17] Meng T, Chang H. Network Pharmacological Research on the Mechanism of Compound Danshen Drops in the Treatment of Acute Myocardial Infarction. Chin J Emerg Med. 2021;30(11):1897-1901, 1928.